Background: Deletion of LacZ gene in E. coli HB101-pBRKan using Clustered Regularly Inter-Spaced Short Palindromic Repeats-Cas9 (CRISPR/Cas9) gene-editing tool. Methodology: Using BioRadTM USA “Out of the blue” gene editing kit, we demonstrated in vitro knockout model for deletion of LacZ gene in E. coli HB101-pBRKan by employing CRISPR/Cas9 gene-editing tool. We followed an already designed modular plasmid assembly strategy and tested a single nuclease. Editing genomic locus was achieved within three days of minimal lab work. Results: We were successful in gene editing of the E. coli LacZ gene using CRISPR/Cas9. Conclusion: With the practical experience gained, we are confident enough to experiment in animal models to tackle the hematological disease.